Co-Authors
This is a "connection" page, showing publications co-authored by Tetsuya Tanimoto and Anju Murayama.
Connection Strength
1.037
-
Coronavirus disease 2019 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies. Clin Microbiol Infect. 2020 Dec 11.
Score: 0.918
-
Limited capacity of SARS-CoV-2 variants testing in Japan: A secondary analysis using publicly available data. Travel Med Infect Dis. 2021 Sep-Oct; 43:102145.
Score: 0.060
-
Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir. Clin Pharmacol Ther. 2022 03; 111(3):545-547.
Score: 0.059